Evaluating of safety and efficacy of Stylux REDENSITY ® mesogel
- Conditions
- skin hydration.Changes in skin textureR23.4
- Registration Number
- IRCT20190210042676N31
- Lead Sponsor
- ovajen Daru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Age between 21 and 55years old
Present visible signs of skin ageing symptoms mainly skin dryness skin roughness, loss of elasticity and appearance of fine lines
Possibility to accompany the visit plans and study process.
Signing an informed consent form and agreed to follow up.
Previous treatment with hyaluronic acid fillers in the facial area within the past year
Systemic diseases affecting skin health such as collagen vascular diseases, diabetes, hypothyroidism, as well as liver and renal failure
Experience with RF, rejuvenation lasers or intense pulsed light in the past 6 months
History of systemic use of skin-related medicine such as glucocorticoids, isotretinoin, immunomodulators and hormonal medicine in the past 3 months
Currently pregnant or lactating
Smoking in the past two years
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stratum corneum hydration. Timepoint: Before intervention, 4 and 12 weeks after the last injection. Method of measurement: Corneometry by MPA 580.
- Secondary Outcome Measures
Name Time Method Skin elasticity. Timepoint: Before intervention, 4 and 12 weeks after the last injection. Method of measurement: Cutometery.;Trans Epidermal Water Loss. Timepoint: Before intervention, 4 and 12 weeks after the last injection. Method of measurement: Tewameter.